NOVAFERON Trademark

Trademark Overview

On Tuesday, December 18, 2018, a trademark application was filed for NOVAFERON with the United States Patent and Trademark Office. The USPTO has given the NOVAFERON trademark a serial number of 88233960. The federal status of this trademark filing is REGISTERED as of Tuesday, November 7, 2023. This trademark is owned by Novagen Holding Corporation. The NOVAFERON trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations for treatment of cancer and viral diseases; proteins for treatment of cancer and viral diseases; protein fragments for treatment of cancer and viral diseases; protein conjugates for treatment of cancer and viral diseases; pharmaceutical preparations, namely, anti-cancer and anti-viral agents; pharmaceutical preparations, proteins, protein fragments and protein conjugates all for treatment of immunologic diseases, particularly autoimmune diseases

Proteins for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; protein fragments for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; protein conjugates for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; anti-cancer and anti-viral agents for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; proteins, protein fragments, and protein conjugates all for use in the manufacture of pharmaceutical preparations for treatment of immunologic diseases, particularly autoimmune diseases
novaferon

General Information

Serial Number88233960
Word MarkNOVAFERON
Filing DateTuesday, December 18, 2018
Status700 - REGISTERED
Status DateTuesday, November 7, 2023
Registration Number7209773
Registration DateTuesday, November 7, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 22, "1b" should be deleted, and "44e" should be inserted.
Goods and ServicesPharmaceutical preparations for treatment of cancer and viral diseases; proteins for treatment of cancer and viral diseases; protein fragments for treatment of cancer and viral diseases; protein conjugates for treatment of cancer and viral diseases; pharmaceutical preparations, namely, anti-cancer and anti-viral agents; pharmaceutical preparations, proteins, protein fragments and protein conjugates all for treatment of immunologic diseases, particularly autoimmune diseases
Pseudo MarkNOVA FERON
Goods and ServicesProteins for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; protein fragments for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; protein conjugates for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; anti-cancer and anti-viral agents for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; proteins, protein fragments, and protein conjugates all for use in the manufacture of pharmaceutical preparations for treatment of immunologic diseases, particularly autoimmune diseases

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, January 10, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 10, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovagen Holding Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGeorge Town GrandCaym
KY
Party NameNovagen Holding Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGeorge Town GrandCaym
KY
Party NameNovagen Holding Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGeorge Town
KY

Trademark Events

Event DateEvent Description
Wednesday, March 20, 2019NON-FINAL ACTION E-MAILED
Friday, December 21, 2018NEW APPLICATION ENTERED
Thursday, January 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 14, 2019ASSIGNED TO EXAMINER
Wednesday, March 20, 2019NON-FINAL ACTION WRITTEN
Wednesday, March 20, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 20, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 4, 2019FINAL REFUSAL WRITTEN
Friday, October 4, 2019FINAL REFUSAL E-MAILED
Friday, October 4, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 2, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, April 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 6, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 26, 2020PUBLISHED FOR OPPOSITION
Tuesday, May 26, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, July 9, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 9, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, January 15, 2021SOU TEAS EXTENSION RECEIVED
Friday, January 15, 2021SOU EXTENSION 1 FILED
Friday, January 15, 2021SOU EXTENSION 1 GRANTED
Tuesday, January 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 19, 2021SOU TEAS EXTENSION RECEIVED
Monday, July 19, 2021SOU EXTENSION 2 FILED
Monday, July 19, 2021SOU EXTENSION 2 GRANTED
Wednesday, July 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 20, 2022SOU TEAS EXTENSION RECEIVED
Thursday, January 20, 2022SOU EXTENSION 3 FILED
Thursday, January 20, 2022SOU EXTENSION 3 GRANTED
Saturday, January 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 21, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 21, 2022SOU EXTENSION 4 FILED
Thursday, July 21, 2022SOU EXTENSION 4 GRANTED
Saturday, July 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 10, 2023SOU EXTENSION 5 FILED
Thursday, January 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 26, 2023SOU EXTENSION 5 GRANTED
Friday, January 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 21, 2023TEAS PETITION TO AMEND BASIS RECEIVED
Monday, July 10, 2023ASSIGNED TO PETITION STAFF
Tuesday, July 18, 2023PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, July 19, 2023NOTICE OF ALLOWANCE CANCELLED
Wednesday, July 19, 2023CASE RETURNED TO EXAMINATION
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 7, 2023REGISTERED-PRINCIPAL REGISTER
Monday, August 26, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 30, 2024CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, January 23, 2024TEAS SECTION 7 REQUEST RECEIVED
Thursday, September 5, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Related Keywords

novaferon diseases cancer viral protein pharmaceutical preparations treatment manufacture treating anti